References
- McGuire W L., Clark G M. Prognostic factors and treatment decisions in axillary node-negative breast cancer. N Engl J Med. 1992; 326: 1756–61
- Wong W W., Vijayakumar S, Weichselbaum R R. Prognostic indicators in node negative early stage breast cancer. Am J Med 1992; 92: 539–48
- Poulson H S. In vitro test and hormonal treatment of breast cancer. Progress in surgical pathology, C M. Fenoglio, M Wolff. Mas-son Publishing USA, New York 1983; 37–65
- Jordan V C., Jacobson H I., Keenan E J. Determination of estrogen receptors in breast cancer using monoclonal antibody technology: results of a mul-ticenter study in United States. Cancer Res 1986; 46(suppl)4237–40
- Wu J T., Wilson L W. Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay. Clin Chem 1988; 34: 1987–91
- Elston C W., Ellis I O. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: Experience from a large study with long-term follow up. Histopathology 1991; 19: 403–10
- Tesch M, Shawwa A, Henderson R. Immunohisto-chemical determination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol 1993; 99: 8–12
- Hanna W, Mobbs B G. Comparative evaluation of ER-ICA and enzyme immunoassay for the quantification of estrogen receptors in breast cancer. Am J Clin Pathol 1989; 91: 182–6
- Negri F, Campani D, Sarnelli, et al. Comparison of monoclonal immunocytochemical and immuno-enzymatic methods for steroid receptor evaluation in breast cancer. Am J Clin Pathol 1991; 96: 53–8
- Helin H J., Helle M J., Kallioniemi O, Isola J J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry. Cancer 1989; 63: 1761–7
- Allred D G. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer. Editorial. Am. J Clin Pathol 1993; 99: 1–3
- Kiang D T., Hollander R. Breast cancer negative for estrogen receptor but positive for progesterone receptor, A true entity?. J Clin Oncol 1987; 5: 662–6